There are currently no effective means to treat acute spinal cord injury, except for glucocorticoids, which produce moderate benefits at best. A new study suggests erythropoietin, now recognized as a potent neuroprotective cytokine, as a potential treatment for spinal cord injury.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Courtesy of A. Louissaint
References
Sekhon, L. & Fehlings, M. Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26, S2–S12 (2001).
Gorio, A. et al. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc. Natl. Acad. Sci. USA 99, 9450–9455 (2002).
Basso, D.M., Beattie, M. & Bresnahan, J. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1–21 (1995).
Juul, S., Anderson, D., Li, Y. & Christensen, R. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatric Res. 43, 40–49 (1998).
Bernaudin, M. et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 19, 643–651 (1999).
Brines, M. et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. 97, 10526–10531 (2000).
Lin, J. et al. Gap junction-mediated propagation and amplification of cell injury. Nature Neurosci. 1, 494–500 (1998).
Celik, M. et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc. Natl. Acad. Sci. 99, 2258–2263 (2002).
Springborg, J. et al. A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid hemorrhage in rats. British J. Pharmacol. 135, 823–829 (2002).
Digicaylioglu, M. & Lipton, S.A. Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signaling cascades. Nature 412, 641–647 (2001).
O'Neill, L. & Kaltscmidt, C. NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends in Neurosci. 20, 252–258 (1997).
Mattson, M., Goodman, Y., Luo, H., Fu, W. & Furukawa, K. Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis. J. Neurosci. Res. 49, 681–697 (1997).
Leventhal, C., Rafii, S., Rafii, D., Shahar, A. & Goldman, S.A. Endothelial trophic support of neuronal production and recruitment by the adult mammalian subependyma. Molec. Cell. Neurosci. 13, 450–464 (1999).
Palmer, T. Adult neurogenesis and the vascular Nietzsche. Neuron 34, 856–858 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goldman, S., Nedergaard, M. Erythropoietin strikes a new cord. Nat Med 8, 785–787 (2002). https://doi.org/10.1038/nm0802-785
Issue Date:
DOI: https://doi.org/10.1038/nm0802-785
This article is cited by
-
Pathobiology of radiation myelopathy and strategies to mitigate injury
Spinal Cord (2015)
-
High-dose erythropoietin has no effect on short- or long-term graft function following deceased donor kidney transplantation
Kidney International (2012)
-
Localization of erythropoietin in and around growing cartilage
Molecular and Cellular Biochemistry (2010)
-
Mechanisms of Disease: the hypoxic tubular hypothesis of diabetic nephropathy
Nature Clinical Practice Nephrology (2008)
-
Mechanisms of Disease: erythropoietin—an old hormone with a new mission?
Nature Clinical Practice Cardiovascular Medicine (2006)
